H.C. Wainwright adjusted the firm’s price target on ProMIS Neurosciences (PMN) to $18 from $4 and keeps a Buy rating on the shares following the reverse stock split.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PMN: